MITRALVALVE DISEASE | Mitral Valve Prolapse Patients with Less than Moderate Mitral Regurgitation Exhibit Early Cardiac Chamber Remodeling

Image of point of care ultrasound emergency ultrasound echocardiogram critical care echocardiography AI abdominal ultrasound    Online PoCUS Training

MITRALVALVE DISEASE | Mitral Valve Prolapse Patients with Less than Moderate Mitral Regurgitation Exhibit Early Cardiac Chamber Remodeling

Source: J Am Soc Echocardiogr 2020;33:815-25


Mitral valve prolapse (MVP), which has a prevalence of 2.4% in the general population, is the most common etiology of mitral regurgitation (MR). The natural history of MVP is diverse, ranging from slow progression of mild MR degrees, to rapid progression to severe MR requiring cardiac surgery. MVP can also lead to infective endocarditis and ‘‘malignant MVP,’’ which is associated with sudden cardiac death.

In patients with severe MR caused by MVP, there is associated eccentric left ventricular (LV) and left atrial (LA) chamber remodeling with LV dilatation, eccentric LV hypertrophy (eLVH), and LA dilatation.

The authors undertook this study of patients with MVP with less than moderate MR to assess:

  1. The presence and severity of LV and LA remodeling
  2. The determinant factors of LV and LA remodeling
  3. If early remodeling is a marker of MR progression


Study population

Consecutive patients with MVP who had with less than moderate MR quatified by proximal isovelocity surface area (PISA) and by the comprehensive integrated transthoracic echocardiography (TTE) approach, were retrospectively identified. The authors then matched them 1:2 for age and sex with non-MVP patients having less than moderate MR (non-MVP control group) by the comprehensive integrated TTE approach.

Exclusion criteria included dysfunction of other valves of moderate or greater degree, left ventricular ejection fraction (LVEF) < 50%, renal dysfunction (creatinine $ 1.3 mg/dL), hypertrophic cardiomyopathy, constrictive pericarditis, prior mitral valve surgeries, and cyanotic congenital heart disease.


Standard TTE was performed with chamber and diastology assessment. Maximal two-dimensional LV dimensions were obtained in the parasternal long-axis view by choosing the largest measurements from basal to mid LV. The LA volume was calculated by the disk summation technique, the LV mass was calculated using linear methods, and MVP was defined per guidelines.

Chamber Remodeling Parameters

The LV remodeling parameters studied were LVend-systolic dimension index (LVESDi), LVend-diastolic dimension index (LVEDDi), LV mass index (LVMi), presence of eLVH (relative wall thickness # 0.42 and LVMi > 95 g/m 2 in women and >115 g/m 2 in men), and LA volume index (LAVi).


A total of 253 MVP patients with less than moderate MR were matched to 344 controls with less than moderate MR. Patients with MVP had more PVCs, larger LV and LA remodeling parameters, and more mild-to-moderate MR. Multivariate linear regression models showed that larger LV remodeling parameters were independently associated with MVP and female sex but not MR severity. The LA volume index was independently associated with MVP, age, and E/e’. The LV mass index was associated with MVP, age, and hypertension. Among 323 (54%) patients having subsequent transthoracic echocardiography, 17 patients (all MVP) progressed to moderate-severe MR or more at a median of 4.3 years. Isolated posterior leaflet prolapse was the single factor associated with MR progression.


The authors concluded that patients with less than moderate degenerative MR due to MVP exhibit ‘‘benign’’ early LV and LA remodeling that appears to be not related to MR severity and not associated with MR progression or mortality.